| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.31 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.24 | 0.08 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.006 |